“A LIPOSOMAL CO-DELIVERY SYSTEM FOR DOXORUBICIN AND AN ANTI-PD-L1 NANOBODY SYNERGIZES CHEMO-IMMUNOTHERAPY IN A MURINE COLON CARCINOMA MODEL”, JMHSR, vol. 2, no. 4, Nov. 2025, doi: 10.65035/3qvcqd73.